Latest News & Features
Europe
Judging by today’s news cycle, you might think that the world of IP is quite advanced when it comes to artificial intelligence . 28 April 2020
Americas
Argentum Pharmaceuticals can’t have a Novartis patent for a multiple sclerosis drug invalidated because it doesn’t have standing to bring the challenge, the US Court of Appeals for the Federal Circuit has ruled. 28 April 2020
Americas
Pfizer has been rebuked by judges for filing thin evidence in support of what the pharma company called its ‘self-evident’ standing to bring a patent challenge. 28 April 2020
Americas
3M has convinced a US judge to grant a restraining order against a New Jersey company it has accused of infringing the 3M trademarks by reselling N95 masks at “grossly inflated” prices amid the COVID-19 pandemic. 27 April 2020
Big Pharma
Massachusetts-based pharmaceutical company Akebia has had five Fibrogen patents for an anaemia treatment invalidated at the English High Court. 23 April 2020
Americas
NASCAR driver Caesar Bacarella’s sports clothing line and supplement business have been hit with a lawsuit by an Australia company. 23 April 2020
Medtech
The UK government’s indemnifying of ventilator manufacturers is a smart solution to potential licensing obstacles, says Andrew Pitts of Mewburn Ellis. 23 April 2020
Americas
The US Court of Appeals for the Federal Circuit has affirmed a lower court’s decision which found that Banner Life Sciences wasn’t infringing a Biogen patent with its bioequivalent version of a multiple sclerosis drug. 23 April 2020
Big Pharma
The COVID-19 pandemic is heightening the dangers posed by the global trade in counterfeit pharmaceutical products, according to the OECD and EUIPO. 22 April 2020
Big Pharma
Pressure is building on IP owners to offer up access to technology that could help fight COVID-19. Rory O'Neill looks at some of the implications for the patent system. 21 April 2020